Clinical trial
Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa
NCT00308776 · New York State Psychiatric Institute, Other · Terminated
Key facts
| NCT number | NCT00308776 |
|---|---|
| Title | Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa |
| Official title | Effect of Cholecystokinin on Binge Eating in Bulimia Nervosa |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Bulimia Nervosa, Eating Disorders |
| Intervention type | Procedure |
| Interventions | Cholecystokinin (CCK) infusion, Saline infusion |
| Enrollment | 6 |
| Start date | Oct 1, 2003 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Mar 30, 2006 |
| Last update posted | May 28, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: